Effective Anti-IL-17 response in psoriasis affecting hard-to-treat places with previous immunobiological failure
- Journal of Dermatology & Cosmetology
Caio Leal Carvalho,<sup>1</sup> Bruna de Quevedo Vinagre,<sup>1</sup> Ivana Nascimento Garcia de Santana,<sup>1</sup> Joelly Taynara Lapinski Levermann,<sup>1</sup> Josimar José Torres,<sup>1</sup> Jouse Maiane Gonçalves Torres,<sup>2</sup> Karine Pereira Neves,<sup>1</sup> Paula Barros Curvo Costa,<sup>3</sup> Vitoria Treichel Cazarotto<sup>1</sup>
PDF Full Text
Psoriasis is a chronic inflammatory systemic disease that predominantly presents with skin, nail and joint manifestations. It can be a disabling disease, both due to the skin lesions and the presence of the articular form. The article aims to report a case of successful treatment of har-to-treat places os psoriasis with an immunobiological drug and reforce the importance of the dermatologist in evaluating and monitoring together with the rheumatologist stands out in patients with seronegative axial arthritis.
psoriasis, psoriatic arthritis, skin diseases, biologicals, dermatologic agents